All cases | Total (%) | XAF1 low (%) | XAF1 high (%) | p-value | |
---|---|---|---|---|---|
 |  | 291 (100) | 152 (52.2) | 139 (47.8) |  |
Gender | Â | Â | Â | Â | 0.212 |
 | Men | 197 (67.7) | 108 (54.8) | 89 (45.2) |  |
 | Women | 94 (32.3) | 44 (46.8) | 50 (53.2) |  |
Age | Â | Â | Â | Â | 0.101 |
 | ≤64 | 142 (48.8) | 67 (47.2) | 75 (52.8) |  |
 | >64 | 149 (51.2) | 85 (57.0) | 64 (43.0) |  |
pT-status | Â | Â | Â | Â | 0.040 |
 | pT1/2 | 145 (49.8) | 67 (46.2) | 78 (53.8) |  |
 | pT3/4 | 146 (50.2) | 85 (58.2) | 61 (41.8) |  |
Fuhrman grade | Â | Â | Â | Â | <0.001 |
 | G 1/2 | 129 (44.3) | 50 (38.8) | 79 (61.2) |  |
 | G 3/4 | 162 (55.7) | 102 (63.0) | 60 (37.0) |  |
Metastases | Â | Â | Â | Â | 0.276 |
 | M0/x | 241 (82.8) | 122 (50.6) | 119 (49.4) |  |
 | M1 | 50 (17.2) | 30 (60.0) | 20 (40.0) |  |